Literature DB >> 16209960

Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction.

Daisaku Nakatani1, Hiroshi Sato, Yasuhiko Sakata, Issei Shiotani, Kunihiro Kinjo, Hiroya Mizuno, Masahiko Shimizu, Hiroshi Ito, Yukihiro Koretsune, Atsushi Hirayama, Masatsugu Hori.   

Abstract

BACKGROUND: In patients with acute myocardial infarction (AMI), depressive symptoms increase the risk for cardiac events. Recently, the S allele of the serotonin transporter (5-HTT) gene-linked polymorphic region was shown to reduce transcription of this gene and thus reduce serotonin reuptake, and this allele is linked with depressive symptoms as well as other psychiatric diseases. However, the influence of the S allele on depressive symptoms and cardiac events after AMI is unclear.
METHODS: To investigate whether the S allele was associated with depressive symptoms and cardiac events after AMI, we prospectively examined depressive symptoms and new cardiac events in 2509 genotyped patients with AMI.
RESULTS: Depressive symptoms were more common in patients with the S allele than in those without it (48.3% vs 35.0%, P = .02). Multivariate analysis revealed that the S allele was independently associated with depressive symptoms (odds ratio 2.19, 95% confidence interval [CI] 1.21-3.98, P = .01). Cardiac events (cardiac death, revascularization, heart failure, reinfarction, arrhythmia, and unstable angina) were more frequent in patients with the S allele than in those without it (31.3% vs 22.3%, P = .046). Multivariate Cox regression analysis revealed an association between the S allele and an increased risk for cardiac events (hazard ratio [HR] 1.69, 95% CI 1.03-2.78, P = .04). However, the HR became insignificant after an adjustment for depressive symptoms (HR 1.30, 95% CI 0.84-2.01, P = .24).
CONCLUSIONS: The S allele in the 5-HTT gene-linked polymorphic region is associated with an increased risk for subsequent cardiac events, which is mediated, at least in part, by the depressive symptoms in patients after AMI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209960     DOI: 10.1016/j.ahj.2005.03.062

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  35 in total

1.  The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation.

Authors:  Katja Karg; Margit Burmeister; Kerby Shedden; Srijan Sen
Journal:  Arch Gen Psychiatry       Date:  2011-01-03

Review 2.  Depression in people with coronary heart disease: prognostic significance and mechanisms.

Authors:  Chris Dickens
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

Review 3.  Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease.

Authors:  Dennis L Murphy; Pablo R Moya
Journal:  Curr Opin Pharmacol       Date:  2011-03-23       Impact factor: 5.547

4.  A prospective cohort study investigating factors associated with depression during medical internship.

Authors:  Srijan Sen; Henry R Kranzler; John H Krystal; Heather Speller; Grace Chan; Joel Gelernter; Constance Guille
Journal:  Arch Gen Psychiatry       Date:  2010-04-05

Review 5.  The impact of depression in heart disease.

Authors:  Yelizaveta Sher; Sermsak Lolak; José R Maldonado
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

6.  Polygenic risk, stressful life events and depressive symptoms in older adults: a polygenic score analysis.

Authors:  K L Musliner; F Seifuddin; J A Judy; M Pirooznia; F S Goes; P P Zandi
Journal:  Psychol Med       Date:  2014-12-09       Impact factor: 7.723

7.  Association of serotonin transporter gene polymorphisms with poststroke depression.

Authors:  Ruth Kohen; Kevin C Cain; Pamela H Mitchell; Kyra Becker; Ann Buzaitis; Steven P Millard; Grace P Navaja; Linda Teri; David Tirschwell; Richard Veith
Journal:  Arch Gen Psychiatry       Date:  2008-11

Review 8.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

9.  Mental disorders and coronary heart disease risk: could the evidence elude us while we sleep?

Authors:  Carmela Alcántara; Karina W Davidson
Journal:  Circulation       Date:  2013-11-04       Impact factor: 29.690

Review 10.  A model for intervention research in late-life depression.

Authors:  George S Alexopoulos; Martha L Bruce
Journal:  Int J Geriatr Psychiatry       Date:  2009-12       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.